Skip to content

Clinical trials

Phase 3 Leukemia, Mast-Cell trials

Search ClinicalTrials.gov registrations by keyword, then narrow by condition, phase, status, country and start year.

Filters: Condition: Leukemia, Mast-Cell Phase: Phase 3 Clear all

5 trials match Source: ClinicalTrials.gov registrations

Trials started per year

By phase, 2000 to 2026.

Trials started per year
CategoryTrials
20051
20061
20082
20091

Status

Trials by registry status. Select a bar to filter.

Trials by status
CategoryTrials
Completed4
Unknown status1

Top lead sponsors

A sponsor with a page on Pharma Observatory links to it.

Top lead sponsors
CategoryTrials
Alliance for Clinical Trials in Oncology1
Case Comprehensive Cancer Center1
Mayo Clinic1
University of Glasgow1
Vanderbilt-Ingram Cancer Center1

Top conditions

MeSH conditions the trials were registered with, not their broader categories. A condition with a page on Pharma Observatory links to it.

Top conditions
CategoryTrials
Burkitt Lymphoma5
Hodgkin Disease5
Immunoblastic Lymphadenopathy5
Immunoglobulin Light-chain Amyloidosis5
Leukemia, Biphenotypic, Acute5
Leukemia, Hairy Cell5
Leukemia, Large Granular Lymphocytic5
Leukemia, Lymphocytic, Chronic, B-Cell5
Leukemia, Mast-Cell5
Leukemia, Prolymphocytic5

Trials

Showing 26 to 5 of 5. Each trial links to its page on Pharma Observatory.

No trials match these filters.

Try a different keyword, or clear a filter.

Recently changed trials

Changes observed in the last 7 days, newest first, site-count changes left out. Source: ClinicalTrials.gov.

No changes to these trials in the last 7 days.

Go deeper on Pharma Observatory

Pharma Observatory connects clinical trials, sponsors, sites and investigators in one searchable platform.